Efficacy of Fire Needle Therapy Combined with Doxycycline Hydrochloride in the Management of Moderate-to-Severe Acne Vulgaris: A Randomized Controlled Trial

火针疗法联合盐酸多西环素治疗中重度寻常痤疮的疗效:一项随机对照试验

阅读:2

Abstract

OBJECTIVE: Fire needle therapy has shown promise in treating acne vulgaris (AV), improving facial lesions and patient quality of life. This study aims to investigate the effects of combining fire needle therapy with doxycycline hydrochloride tablets (DHT) on the Global Acne Grading System (GAGS), the échelle d'évaluation clinique des cicatrices d'acné (ECCA) grading scale, the Dermatology Life Quality Index (DLQI), and the serum levels of inflammatory factors interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in patients with moderate-to-severe AV. METHODS: 70 patients with moderate-to-severe AV were randomly assigned to the control group (n=35) to receive oral DHT treatment once a day and the intervention group (n=35) to be treated with fire needle therapy on the basis of DHT once a week. The total treatment duration for both groups was 8 weeks. Therapeutic efficacy was evaluated at the 4-week and 8-week marks. The primary outcome measure evaluated was the GAGS score. The secondary outcome measures included the ECCA score, the DLQI score, and the serum levels of the inflammatory factors IL-17, TNF-α, and IL-6. RESULTS: Compared to baseline data, both groups exhibited marked improvements in skin lesions at both the 4-week and 8-week treatment marks. Significant reductions were observed in the GAGS, ECCA, and DLQI scores, as well as in the serum levels of the inflammatory factors IL-17, TNF-α, and IL-6. Notably, the intervention group demonstrated significantly greater improvements than the control group at both the 4-week and 8-week assessments. CONCLUSION: An 8-week regimen of fire needle therapy combined with DHT improved lesion severity, scar symptoms, quality of life, and serum inflammatory cytokine levels in patients with moderate-to-severe AV compared to DHT monotherapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。